A Study of LY3437943 in Participants With Impaired and Normal Liver Function
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to measure how much of LY3437943 gets into the bloodstream
and how long it takes the body to eliminate it in participants with mild, moderate and severe
impaired liver function compared to healthy participants with normal liver function. The
safety and tolerability of LY3437943 will also be evaluated. The study may last up to 9 weeks
for each participant including the screening period.